Bio-Rad Laboratories (BIO) Assets Average (2010 - 2026)

Bio-Rad Laboratories (BIO) has 17 years of Assets Average data on file, last reported at $10.2 billion in Q1 2026.

• On a quarterly basis, Assets Average rose 106.85% year-over-year to $10.2 billion in Q1 2026; TTM through Mar 2026 was $10.2 billion, a 106.85% increase from a year earlier, with the FY2025 full-year figure at $10.0 billion, up 102.29% from the prior year.
• Assets Average for Q1 2026 stood at $10.2 billion, roughly flat from $10.1 billion in the prior quarter.
• Over the last five years, Assets Average for BIO reached as high as $13.5 billion in Q2 2022 and fell as low as $246.6 million in Q2 2025.
• Historically, Assets Average has averaged $7.5 billion across 5 years, with a median of $6.8 billion in 2023.
• Across the five-year window, Assets Average slumped 92.79% in 2024 and soared 899.81% in 2025, its largest moves.
• Year by year, Assets Average stood at $6.0 billion in 2022, then increased by 2.74% to $6.2 billion in 2023, then decreased by 21.96% to $4.8 billion in 2024, then surged by 109.68% to $10.1 billion in 2025, then increased by 0.46% to $10.2 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $10.2 billion in Q1 2026, $10.1 billion in Q4 2025, and $4.9 billion in Q3 2025.